# EDGAR Filing Document

**Accession Number:** 0001900590
**File Stem:** 0001900590-26-000003
**Filing Date:** 2026-5
**Character Count:** 2940
**Document Hash:** 54182387376ca2eae23223e041770824
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001900590-26-000003.hdr.sgml**: 20260513

**ACCESSION NUMBER**: 0001900590-26-000003

**CONFORMED SUBMISSION TYPE**: C-AR

**CONFIRMING COPY**: 

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260513

**DATE AS OF CHANGE**: 20260513

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AJNA BioSciences PBC
- **CENTRAL INDEX KEY:** 0001900590

**ORGANIZATION NAME:**
- **EIN:** 863415682
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-35836

**BUSINESS ADDRESS:**
- **STREET 1:** HIGH POINTE BUSINESS CENTER
- **STREET 2:** 8022 SOUTHPARK CIRCLE
- **CITY:** LITTLETON
- **STATE:** CO
- **ZIP:** 80120
- **BUSINESS PHONE:** 7206150515

**MAIL ADDRESS:**
- **STREET 1:** 8022 SOUTHPARK CIRCLE, SUITE 500
- **STREET 2:** SUITE 500
- **CITY:** LITTLETON
- **STATE:** CO
- **ZIP:** 80120

### Attached PDF Documents

**Attachment 1:** `formc-ar.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** AJNA BioSciences PBC

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 04-21-2021

**Physical Address:** 8022 SOUTHPARK CIRCLE, SUITE 500, Littleton, CO, 80120

**Issuer Website:** https://www.ajnabiosciences.com/

**Is there a Co-Issuer?:** No

### Offering Information

**Oversubscription Accepted:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 16

**Total Assets (Most Recent Fiscal Year):** $13,800,386.00

**Total Assets (Prior Fiscal Year):** $16,627,450.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $368,452.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $1,927,679.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $1,496,442.00

**Short-Term Debt (Prior Fiscal Year):** $512,725.00

**Long-Term Debt (Most Recent Fiscal Year):** $385,819.00

**Long-Term Debt (Prior Fiscal Year):** $1,953,013.00

**Revenues/Sales (Most Recent Fiscal Year):** $1,692,791.00

**Revenues/Sales (Prior Fiscal Year):** $3,267,479.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $1,692,791.00

**Cost of Goods Sold (Prior Fiscal Year):** $3,267,479.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $30,000.00

**Net Income (Most Recent Fiscal Year):** $-3,800,746.00

**Net Income (Prior Fiscal Year):** $-2,359,584.00

### Signatures

**Issuer:** AJNA BioSciences PBC

**Signature:** Joel Stanley

**Title:** Chief Executive Officer

---

**Signature:** Joel Stanley

**Title:** Chief Executive Officer

**Date:** 05-13-2026